Anlotinib plus Chemotherapy for the Treatment of Refractory Primary Cardiac Intimal Sarcoma: A Case Report
To our knowledge, this is the first report describing the therapeutic efficacy of anlotinib in CIS. This case highlights the potential role of anlotinib as a promising therapeutic option for this rare and aggressive malignancy.
Authors
- Wenqiang Guan
- Jidong Miao
- Hongyu Guan
Institutions
- Soochow University (CN)
- Zigong First People's Hospital (CN)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1159/000550234
- Primary Topic
- Cardiac tumors and thrombi
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wu Jieping Medical Foundation